Continuous infusion of recombinant factor VIIa (NovoSeven) in the treatment of a patient with type III von Willebrand’s disease and alloantibodies against von Willebrand factor - Grossmann,R.E.; Geisen,U.; Schwender,S.; Keller,F. (Thromb Haemost, 2000)